Shin Poong Pharmaceutical Co., Ltd. (002870) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Shin Poong Pharmaceutical Co., Ltd. (002870:KRX), powered by AI.

Current Price
₩1,242
P/E Ratio
21.7
Market Cap
43.4B
Sector
Consumer Cyclical
What is the Shin Poong Pharmaceutical Co., Ltd. stock price forecast?

Shin Poong Pharmaceutical Co., Ltd. is currently trading at ₩1,242. View real-time AI analysis on Alpha Lenz.

What is Shin Poong Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Shin Poong Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Shin Poong Pharmaceutical Co., Ltd.'s P/E ratio?

Shin Poong Pharmaceutical Co., Ltd.'s P/E ratio is 21.7.

Shin Poong Pharmaceutical Co., Ltd.

KRX · 002870
₩1,242+209(+20.23%)Market closedKRX regular session 09:00–15:30 KST
Ask about Shin Poong Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Shin Poong Pharmaceutical Co., Ltd. trades at a P/E of 21.7 (fair value) with modest ROE of 2.8%.

Ask for details

Company Overview

Shin Poong Pharmaceutical Co., Ltd. is a healthcare company that focuses on the development, manufacturing, and marketing of pharmaceutical products. With its foundation rooted in creating effective solutions for medical needs, Shin Poong is renowned for its contributions to the pharmaceutical industry, particularly in developing treatments for tropical and infectious diseases. The company's extensive product range includes ethical drugs, over-the-counter medications, and APIs (Active Pharmaceutical Ingredients), which play a crucial role in healthcare systems worldwide. Shin Poong Pharmaceutical is committed to research and innovation, leveraging cutting-edge technology and partnerships to enhance its product offerings in various therapeutic areas. This commitment places the company at the forefront of addressing global health challenges, particularly in underserved regions, thereby making a significant impact on public health outcomes. In the financial market, Shin Poong Pharmaceutical represents a key player in the pharmaceutical and healthcare sectors, reflecting both growth potential and stability. Its proactive approach to R&D and strategic collaborations underscore its importance and influence within the industry, contributing to its stature as a reliable entity in advancing medical science and healthcare delivery.

CEO정학헌
SectorConsumer Cyclical
IndustryPackaging & Containers
Employees22

Company Statistics

FY 2025

Profile

₩43,418,705,400Market Cap
₩24,228,056,500Revenue
34.96MShares Out
22Employees

Margins

17.63%Gross
-0.56%EBITDA
-9.12%Operating
8.26%Pre-Tax
8.26%Net

Valuation

21.70P/E
0.59P/B
1.79EV/Sales
-261.71EV/EBITDA
18.88P/FCF

Growth (CAGR)

8.86%Rev 3Yr
-6.43%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
-42.88%Net Inc 5Yr

Returns

2.64%ROA
2.75%ROE
2.75%ROIC

Financial Health

₩8,654,755,980Cash & Cash Equivalents
₩-5,815,889,140Net Debt
3.85%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Shin Poong Pharmaceutical Co., Ltd. (ticker: 002870) is a company listed on KRX in the Consumer Cyclical sector (Packaging & Containers). It has approximately 22 employees. Market cap is $43.4B.

The current price is ₩1,242 with a P/E ratio of 21.7x and P/B of 0.59x.

ROE is 2.75% and operating margin is -9.12%. Annual revenue is $24.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Shin Poong Pharmaceutical Co., Ltd. (002870) Stock Forecast 2026 ₩1,242 — Price, Financials & Analyst Targets | Alpha Lenz